CD4 and tuberculosis: Furthermore, since more than 50% of the HIV/TB patients in Sub-Saharan Africa presented to the health facilities at advanced disease stages and start ART at CD4+ counts of 100–150 cells/μl[16,24] the benefit of patients on ART could be limited[28,39].